Clinical Trial Detail

NCT ID NCT01813734
Title Ponatinib in Advanced NSCLC w/ RET Translocations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Ponatinib

Age Groups: adult

Additional content available in CKB BOOST